Ling Xue

Ling Xue is an accomplished Executive Director of Portfolio and Program Management at BeiGene, with experience spanning from February 2015 to present, overseeing portfolio management and coaching junior team members. Prior roles include Senior Director and Director of Clinical Development, where responsibilities involved clinical trial strategy, regulatory submissions, and collaboration with clinical operations. Previously, Ling served as a Scientist III and II at Pharmacyclics, focusing on drug resistance mechanisms, and as a Senior Scientist at BioGenex, developing cancer biomarkers. Early career experiences include research at UC Berkeley, contributing to significant findings in cancer biology, culminating in a Ph.D. in Cancer Biology, alongside a master’s and bachelor’s degree in Biochemistry and Molecular Biology from Nankai University.